David Bachman to Neuropsychological Tests
This is a "connection" page, showing publications David Bachman has written about Neuropsychological Tests.
Connection Strength
1.004
-
A comparison of four embedded validity indices for the RBANS in a memory disorders clinic. Arch Clin Neuropsychol. 2015 May; 30(3):207-16.
Score: 0.415
-
Embedded indices of effort in the repeatable battery for the assessment of neuropsychological status (RBANS) in a geriatric sample. Clin Neuropsychol. 2010 Aug; 24(6):1064-77.
Score: 0.298
-
Neurocognitive impairment in obstructive sleep apnea. Chest. 2012 Jun; 141(6):1601-1610.
Score: 0.086
-
Intact cognition in depressed elderly veterans providing adequate effort. Arch Clin Neuropsychol. 2011 Apr; 26(3):184-93.
Score: 0.078
-
Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis? Cerebrovasc Dis. 2017; 43(1-2):31-35.
Score: 0.029
-
Effect of methylphenidate on attention in apathetic AD patients in a randomized, placebo-controlled trial. Int Psychogeriatr. 2014 Feb; 26(2):239-46.
Score: 0.024
-
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013 Aug; 74(8):810-6.
Score: 0.023
-
Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology. 1993 Mar; 43(3 Pt 1):515-9.
Score: 0.023
-
Preliminary examination of progression of Alzheimer's disease in a rural Southern African American cohort. Arch Clin Neuropsychol. 2007 Mar; 22(3):405-14.
Score: 0.015
-
Effectiveness of a continuum of care using brief and partial hospitalization for agitated dementia patients. Psychiatr Serv. 1997 Nov; 48(11):1435-9.
Score: 0.008
-
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol. 1995 May; 52(5):485-90.
Score: 0.007